FNY Investment Advisers’s Syra Health Corp. Class A Common Stock SYRA Stock Holding History

FNY Investment Advisers’s Portfolio SYRA Stock Details SYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,500	Closed	-$4K	–	806
2023 Q3	$4K	Buy	+1,500	New	+$4.5K	﹤0.01%	487

Other funds holding SYRA

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FNY Investment Advisers's SYRA Position: Q4 2023 in Review

FNY Investment Advisers sold out of Syra Health Corp. Class A Common Stock (SYRA) in Q4 2023, closing a stake of 1,500 shares — an estimated $4K sold.

FNY Investment Advisers first reported a position in SYRA in Q3 2023 and held it in 1 quarter. The position peaked at $4K in Q3 2023. 6 funds tracked by Wall St. Rank hold SYRA as of Q4 2023.

FNY Investment Advisers reported no remaining Syra Health Corp. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
FNY Investment Advisers sold 1,500 Syra Health Corp. Class A Common Stock shares in Q4 2023, an estimated $4K.
FNY Investment Advisers first reported a position in Syra Health Corp. Class A Common Stock in Q3 2023 and held it in 1 quarter.
FNY Investment Advisers's Syra Health Corp. Class A Common Stock position peaked at $4K in Q3 2023.
6 funds tracked by Wall St. Rank held Syra Health Corp. Class A Common Stock as of Q4 2023.

Based on FNY Investment Advisers's 13F filing for Q4 2023, filed 12 Jan 2024.